Zhilin Jiang Selected Research

Arsenazo III

1/2022

Targeted Immunoimaging of Tumor-Associated Macrophages in Orthotopic Glioblastoma by the NIR-IIb Nanoprobes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhilin Jiang Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 01/2016
4	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2020 - 01/2018
3	Inflammation (Inflammations) 03/2022 - 01/2020
3	COVID-19 01/2022 - 01/2020
2	Familial Exudative Vitreoretinopathies 01/2022 - 07/2016
2	Gliosis 01/2020 - 01/2018
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2022
1	Atrophy 03/2022
1	Diabetes Mellitus 03/2022
1	Diarrhea 03/2022
1	Fever (Fevers) 03/2022
1	Disease Progression 03/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Insulin Resistance 12/2021
1	Diabetes Complications 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Thrombosis (Thrombus) 12/2021
1	Heart Diseases (Heart Disease) 01/2020
1	Atherosclerosis 01/2020
1	Pulmonary Arterial Hypertension 01/2020
1	Ventricular Remodeling 01/2020
1	Vitelliform Macular Dystrophy 01/2020
1	Myopia 06/2018
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Lymphatic Metastasis 01/2016
1	Adenocarcinoma of Lung 01/2016
1	Ischemic Stroke 01/2013

Drug/Important Bio-Agent (IBA)

3	Retinaldehyde (Retinal)IBA 01/2020 - 07/2016
2	LipidsIBA 12/2021 - 01/2020
2	Glial Fibrillary Acidic ProteinIBA 01/2020 - 01/2018
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2018 - 01/2018
1	decabromobiphenyl ether (decabromodiphenyl ether)IBA 03/2022
1	puerarinIBA 03/2022
1	interleukin-21 (interleukin 21)IBA 03/2022
1	Interferon-gamma (Interferon, gamma)IBA 03/2022
1	InterleukinsIBA 03/2022
1	IsoflavonesIBA 03/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022
1	Interleukin-18 (Interleukin 18)IBA 03/2022
1	ProdrugsIBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	ThiophenesIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	IonsIBA 01/2022
1	Arsenazo IIIIBA 01/2022
1	EnzymesIBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	InterferonsIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	AntigensIBA 01/2021
1	trioctyl phosphine oxide (TOPO)IBA 09/2020
1	PoisonsIBA 09/2020
1	SolutionsIBA 09/2020
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2020
1	OligosaccharidesIBA 09/2020
1	hydroxide ionIBA 09/2020
1	guanxin shutongIBA 01/2020
1	Apolipoproteins E (ApoE)IBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	Proteoglycans (Proteoglycan)IBA 01/2020
1	qiliqiangxinIBA 01/2020
1	Capsules (Microcapsules)IBA 01/2020
1	CollagenIBA 01/2020
1	Collagen Type XIIBA 06/2018
1	Collagen Type XVIII (Type XVIII Collagen)IBA 06/2018
1	c-Mer Tyrosine KinaseIBA 03/2018
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Untranslated RNA (Noncoding RNA)IBA 01/2016
1	Long Noncoding RNAIBA 01/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2013

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2020
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 01/2020
1	Immunomodulation 03/2022
1	Drug Therapy (Chemotherapy) 12/2021
1	Lasers (Laser) 01/2020